Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 28;18(11):13283-96.
doi: 10.3390/molecules181113283.

Conformational analysis of geometric isomers of pitavastatin together with their lactonized analogues

Affiliations

Conformational analysis of geometric isomers of pitavastatin together with their lactonized analogues

Damjan Makuc et al. Molecules. .

Abstract

Super-statins are synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, which is the rate-limiting enzyme responsible for the biosynthesis of cholesterol. All of the super-statins with a C=C double bond spacer between the heterocyclic and the dihydroxycarboxylic moiety that are currently on the market exist as E-isomers. To extend the understanding of conformational and thermodynamic preferences of Z-isomeric super-statin analogues, this study focused on analyzing pitavastatin and its lactonized derivatives via NMR spectroscopy and ab initio calculations. Z-isomeric pitavastatin analogues exist in solution as a pair of interconverting rotamers, where the Gibbs free energies between the major and minor rotamers are within 0.12 and 0.25 kcal mol-1 and the rotational energy barriers are between 15.0 and 15.9 kcal mol-1. The analysis of long-range coupling constants and ab initio calculations revealed that rotation across the C5'-C7 single bond is essential for generating a pair of atropisomers. The overall comparison of the results between Z-isomeric pitavastatin and rosuvastatin analogues demonstrated that the former are to some extent more flexible to attain numerous conformations. Demonstrating how structural differences between super-statin analogues induce distinctive conformational preferences provides important insight into the super-statins' conformational variability and may well improve future drug design.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of Z-isomeric pitavastatin (P-1, P-2, P-3) and rosuvastatin analogues (R-1, R-2, R-3), together with atom numbering for 4-O-TBS protected lactone 1, deprotected lactone 2, and calcium salt 3 of the corresponding super-statin analogue (R = 4-F–C6H4).
Scheme 1
Scheme 1
Synthesis of Z-isomers of pitavastatin analogues.
Figure 2
Figure 2
1H-NMR (600 MHz) spectra of (a) P-1 in acetone-d6 in the range from 223 to 323 K; (b) P-2 in acetone-d6 in the range from 223 to 303 K; (c) P-3 in methanol-d4 in the range from 223 to 303 K.
Figure 3
Figure 3
Van’t Hoff plots for dynamic conformational equilibrium M ⇄ m of P-1 (▲), P-2 (■), and P-3 (●) in the temperature range from 223 K to 253 K. The straight lines are the best fits to the experimental data using least-square method. Pearson correlation coefficient R2 was 0.9918, 0.9965, and 0.9941 for P-1, P-2, and P-3, respectively.
Figure 4
Figure 4
Relative potential energy profile of P-1 as a function of the torsion angles ϕ [C6'–C5'–C7–H7] () and θ [H5–C5–C6–H6] () at the B3LYP/6-311+G(d,p) level of theory.
Figure 5
Figure 5
The energetically minimized preferred conformations of P-1 at the B3LYP/6-311+G(d,p) level of theory. For clarity, the tert-butyldimethylsilyl group attached to C3 is not presented (although it was included in calculations).

References

    1. Časar Z. Historic overview and recent advances in the synthesis of super-statins. Curr. Org. Chem. 2010;14:816–845. doi: 10.2174/138527210791111858. - DOI
    1. Singh N., Tamariz J., Chamorro G., Medina-Franco J.L. Inhibitors of HMG-CoA reductase: Current and future prospects. Mini Rev. Med. Chem. 2009;9:1272–1283. doi: 10.2174/138955709789878105. - DOI - PubMed
    1. Fuenfschilling P.C., Pascale H., Mutz J.-P. An improved manufacturing process for fluvastatin. Org. Process Res. Dev. 2007;11:13–18. doi: 10.1021/op060191b. - DOI
    1. Roth B.D., Blankley C.J., Chucholowski A.W., Ferguson E., Hoefle M.L., Ortwine D.F., Newton R.S., Sekerke C.S., Sliskovic D.R., Stratton C.D., et al. Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus. J. Med. Chem. 1991;34:357–366. doi: 10.1021/jm00105a056. - DOI - PubMed
    1. Watanabe M., Koike H., Ishiba T., Okada T., Sea S., Hirai K. Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors. Bioorg. Med. Chem. 1997;5:437–444. doi: 10.1016/S0968-0896(96)00248-9. - DOI - PubMed

Publication types

LinkOut - more resources